In Vitro Diagnostics (IVD) Market Growth Analysis, Trends Forecast by Regions and Types to 2025
18th January 2021 – The global In Vitro Diagnostics (IVD) Market size is likely to reach USD 98.99 billion by 2025 and is anticipated to grow at a CAGR of 6.6% during the forecast period. In-Vitro diagnostics is an extensive range of veterinary and medical laboratory tests that are used to analyze diseases and constantly monitor the clinical status of patients using samples of blood, cells, or other tissues attained from a patient. Considering its driving factors, the growing geriatric population that is very much susceptible to diseases, needs constant diagnostic tests. Additionally, technological expansions in terms of precision, compactness, and cost-effectiveness are helping the market to fast-track the demand for In-Vitro diagnostics industry in the current scenario.
In addition to this, there is a continuous rise in the demand
for Point-of-Care (PoC) devices and the improved technologies such as
miniaturization of microfluidics, biochips, and nano-biotechnology are now
being introduced, which are expected to boost the demand for PoC products.
These improvements will eventually lead to an upsurge in the access to
point-of-care diagnostic tests and are likely to facilitate rapid and effective
test results and will aid the In-Vitro diagnostics market to experience massive
growth during the forecast period.
Access
In Vitro Diagnostics (IVD) Market Report with
The In Vitro diagnostics (IVD) industry is segmented on the
basis of product & service (Reagents & Kits, Instruments,
Fully-automated Instruments, Semi-automated Instruments, Others, Data
Management Software, Services); Technology segment comprises
(Immunochemistry/Immunoassay (Enzyme-Linked Immunosorbent Assay (ELISA),
Chemiluminescence Immunoassay (CLIA), Fluorescence Immunoassay (FIA),
Colorimetric Immunoassay (CI), Radioimmunoassays (RIA), Rapid Tests,Western
Blot, ELISPOT), Clinical Chemistry (Basic Metabolic Panel, Electrolyte Panel,
Liver Panel, Lipid Profile, Renal Profile, Thyroid Function Panel, Specialty
Chemicals), Molecular Diagnostics (Polymerase Chain Reaction (PCR), Isothermal
Nucleic Acid Amplification Technology (INAAT), Hybridization (In-situ
Hybridization & FISH), DNA Sequencing & NGS, Microarray, Others),
Microbiology, Hematology, Coagulation & Hemostasis, Urinalysis, Others);
Application category includes (Diabetes, Infectious Diseases,
Oncology/Cancer, Cardiology, Nephrology, Autoimmune Diseases, Drug
Testing/Pharmacogenomics, HIV/AIDS, Others); End user segmentation for In Vitro
Diagnostics market includes (Laboratories (Large/Reference Laboratories,
Medium-sized Laboratories, Small Laboratories), Hospitals, Academics,
Point-Of-Care Testing, Patient Self-Testing, Others) and by region (North
America, Europe, Asia Pacific, Latin America, Middle East & Africa). Based
on product, reagents & kits dominated the In Vitro diagnostics industry and
held the highest market share as the usage of IVD testing has increased. Along
with this, taking the technology insights into consideration, clinical
chemistry controlled the market by generating higher revenue.
Geographically, North America is expected to dominate the IVD
market as it holds the largest market share owing to the availability of
government funds, and increase in the usage of molecular diagnostics in cancer
screening and genetic disorders. Followed by this, Asia Pacific is likely to
command the highest growth rate during the estimated time span due to the rise
in the number of hospitals and an increase in healthcare expenditure. In the
near future In-Vitro diagnostics (IVD) industry will continue to come up with
some extraordinary product innovations to attract new consumers and investors,
for them to continue the domination.
Some of the prominent key players outlined in the In-Vitro
diagnostics (IVD) market report are Cepheid, Siemens Healthineers, Qiagen,
bioMerieux SA, Sysmex Corporation, Hologic, Inc. (Gen-Probe), F. Hoffmann-La
Roche Ltd., Becton, Dickinson and Company, Hologic, Inc. (Gen-Probe), Abbott,
Alere and Danaher. All the leading companies are including mergers and
acquisitions, partnerships and joint ventures to enhance the growth of the
market efficiently.
Comments
Post a Comment